KOZARICH JOHN W sold 1.0% of their position (467.00 shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $91.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−92.00
Price / share
$193.86
Trade value
$17.83K
% of position
Common Stock
Shares
−179.00
Price / share
$194.76
Trade value
$34.86K
% of position
Common Stock
Shares
−47.00
Price / share
$195.80
Trade value
$9.20K
% of position
Common Stock
Shares
−4.00
Price / share
$196.34
Trade value
$785.38
% of position
Common Stock
Shares
−92.00
Price / share
$197.72
Trade value
$18.19K
% of position
Common Stock
Shares
−23.00
Price / share
$199.22
Trade value
$4.58K
% of position
Common Stock
Shares
−30.00
Price / share
$200.02
Trade value
$6K
% of position
Net shares
−467.00
Net value
-$91.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | S · Sale | −92.00 | $193.86 | $17.83K | 0.2% | 44.59K | 44.50K |
| Common Stock Direct | 12/1/2025 | S · Sale | −179.00 | $194.76 | $34.86K | 0.4% | 44.50K | 44.32K |
| Common Stock Direct | 12/1/2025 | S · Sale | −47.00 | $195.80 | $9.20K | 0.1% | 44.32K | 44.27K |
| Common Stock Direct | 12/1/2025 | S · Sale | −4.00 | $196.34 | $785.38 | 0.0% | 44.27K | 44.27K |
| Common Stock Direct | 12/1/2025 | S · Sale | −92.00 | $197.72 | $18.19K | 0.2% | 44.27K | 44.17K |
| Common Stock Direct | 12/1/2025 | S · Sale | −23.00 | $199.22 | $4.58K | 0.1% | 44.17K | 44.15K |
| Common Stock Direct | 12/1/2025 | S · Sale | −30.00 | $200.02 | $6K | 0.1% | 44.15K | 44.12K |
| Total | −467.00 | -$91.46K | ||||||